President Luiz Inácio Lula da Silva of Brazil and World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus have issued a high-level appeal to the leaders of the G7, G20, and BRICS nations, demanding the immediate finalization of the Pathogen Access and Benefit-Sharing (PABS) system. This joint communique, sent from Geneva and Brasília, arrives at a pivotal moment as international negotiators prepare for a decisive round of talks scheduled from July 6 to 17. The leaders argue that the world remains dangerously vulnerable to future health crises until the final legal annexes of the WHO Pandemic Agreement are ratified and implemented.
The appeal underscores a critical "missing piece" in the global health architecture: a standardized, legally binding framework for sharing pathogen samples and genetic sequences in exchange for guaranteed access to the resulting medical countermeasures. While the broader Pandemic Agreement was adopted in principle following the devastating lessons of the COVID-19 pandemic, the PABS annex remains the primary point of contention. According to the joint letter, the inability to conclude this specific agreement leaves the entire treaty in a state of limbo, effectively preventing it from entering into force and leaving the global community "unprepared" for the next inevitable outbreak.
The Pathogen Access and Benefit-Sharing (PABS) Mechanism
The PABS system is designed to rectify the deep-seated inequities that characterized the global response to COVID-19. At its core, the mechanism operates on a reciprocal "fair bargain" model. Developing nations, which are often the front lines for emerging zoonotic diseases, are expected to share biological materials and genetic sequence data (GSD) of pathogens with pandemic potential immediately. In return, the system would mandate that pharmaceutical manufacturers and developed nations provide equitable access to the diagnostics, therapeutics, and vaccines developed using that shared data.
During the height of the COVID-19 crisis, the absence of such a framework led to what many termed "vaccine apartheid," where high-income countries secured the vast majority of initial vaccine supplies while lower-income nations faced prolonged delays. President Lula and Dr. Tedros emphasize that the PABS annex is not a matter of charity but a strategic necessity. By containing an outbreak at its source through the rapid deployment of tools to the affected region, the global community can prevent a localized threat from escalating into a multi-trillion-dollar global disaster.
The leaders noted that the current system is "improvised case by case," leading to legal uncertainty for laboratories and manufacturers. A unified PABS framework would provide the predictability required for the private sector to invest in research and development while ensuring that the "benefits of shared pathogens" are distributed based on public health needs rather than purchasing power.
Economic and Humanitarian Costs of Unpreparedness
To bolster their argument for urgency, the joint communique cited staggering data from the World Health Organization and the International Monetary Fund (IMF). Estimates suggest that the COVID-19 pandemic claimed as many as 20 million lives globally, far exceeding official death tolls reported during the crisis. The human toll was matched by a catastrophic economic impact; the IMF estimates that the pandemic cost the global economy over $13 trillion in lost output.
The letter argues that the investment required to maintain a robust PABS system and a functional Pandemic Agreement is negligible when compared to the costs of another global shutdown. Beyond the financial figures, the leaders highlighted the ongoing struggle against an Ebola outbreak in Central Africa, where responders continue to work without approved cures or vaccines in some regions, illustrating that the threat of high-pathogenicity viruses is a present reality rather than a distant theoretical possibility.
Addressing Concerns Over National Sovereignty
A significant portion of the joint appeal was dedicated to debunking persistent misinformation regarding the scope of the WHO’s authority under the new agreement. Critics and some political factions in various member states have argued that the Pandemic Agreement would grant the WHO the power to impose national lockdowns, travel restrictions, or mandatory vaccination policies, thereby compromising state sovereignty.
President Lula and Dr. Tedros explicitly addressed these concerns by referencing Article 22, paragraph 2 of the draft agreement. This clause clarifies that the WHO has no authority to direct or alter a country’s domestic laws or policies. Decisions regarding public health interventions remain the exclusive domain of sovereign states. The PABS annex, they clarified, is a technical and logistical framework for resource sharing and does not grant the WHO any executive power over national governance. The leaders urged heads of state to instruct their negotiators to "reach for consensus with courage rather than caution," moving past political hesitations rooted in misconceptions about the treaty’s legal reach.
Chronology of Negotiations and the Road to July
The journey toward a global pandemic treaty began in earnest in December 2021, when the World Health Assembly (WHA) established an Intergovernmental Negotiating Body (INB) to draft and negotiate a convention or agreement under the WHO Constitution.
- December 2021: The WHA holds a special session, the second in its history, to initiate the treaty process.
- 2022–2023: Multiple rounds of INB meetings take place in Geneva, focusing on equity, research and development, and health workforce strengthening.
- May 2024: Member states conclude a high-stakes session on May 1. While significant progress is made on the core text of the Pandemic Agreement, the PABS annex remains unresolved due to disagreements over the percentage of vaccine production to be set aside for global distribution and the financial contributions of the private sector.
- July 6–17, 2024: The upcoming negotiating window is identified as the "deadline" by Lula and Tedros. They have called on leaders to treat this round not as a mere milestone, but as the final opportunity to close the gaps.
The July session is expected to focus on the "hardest questions," such as how the system is governed and how to guarantee that access and benefit-sharing are operationalized in practice rather than just mentioned in the preamble.
Environmental Drivers and the Escalating Risk Profile
The joint letter contextualizes the need for urgency within a broader environmental and technological framework. Scientists estimate there is a 25% chance of another pandemic occurring within the next decade. This heightened risk is driven by several converging factors:
- Climate Change: Rising global temperatures are shifting the habitats of disease-carrying vectors like mosquitoes and ticks, bringing tropical diseases to previously temperate zones.
- Land Use and Agriculture: Encroachment into wilderness areas and the intensification of livestock farming increase the frequency of "spillover" events where viruses jump from animals to humans.
- Biotechnology Risks: While advances in biotech are essential for vaccine development, the leaders noted that uneven biosafety standards globally raise the risk of accidental or deliberate pathogen release.
The communique asserts that the "comfortable belief that outbreaks begin only in distant places is no longer true." Future hotspots could emerge in any nation, regardless of its level of development, making a globalized response system a matter of national security for all.
Geopolitical Implications and Official Responses
The involvement of President Lula is particularly significant given Brazil’s 2024 presidency of the G20. Under Brazil’s leadership, the G20 has, for the first time, formally recognized inequality as a primary driver of pandemic vulnerability. By co-authoring this letter with Dr. Tedros, Lula is positioning the "Global South" as a proactive partner in global health security rather than a passive recipient of aid.
While official responses from the G7 and BRICS secretariats are pending the start of the July negotiations, diplomats in Geneva have noted a "cautious optimism." Representatives from the European Union have previously expressed support for the treaty but have remained firm on protecting intellectual property rights—a key sticking point in the PABS negotiations. Conversely, the African Group and other developing blocs continue to push for a mandatory 20% allocation of pandemic-related health products to the WHO for distribution to needy nations.
The joint appeal by Lula and Tedros serves as a reminder that the technical details of the PABS annex carry profound moral and practical weight. They conclude by framing the agreement as the "natural next chapter" in a legacy of human health achievements, such as the eradication of smallpox and the near-elimination of polio.
As negotiators head back to the table in Geneva this July, the eyes of the global community are on the G7, G20, and BRICS leaders. The message from the WHO and the Brazilian presidency is clear: the cost of delay is measured in trillions of dollars and millions of lives. The "last piece of the puzzle" is now a matter of political will, requiring a transition from technical debate to executive action to ensure that the promise of "never again" is finally kept.
